These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The development of myeloperoxidase inhibitors. Galijasevic S Bioorg Med Chem Lett; 2019 Jan; 29(1):1-7. PubMed ID: 30466896 [TBL] [Abstract][Full Text] [Related]
8. The role of myeloperoxidase in the pathogenesis of coronary artery disease. Nicholls SJ; Hazen SL Jpn J Infect Dis; 2004 Oct; 57(5):S21-2. PubMed ID: 15507760 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients. Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein stimulates myeloperoxidase release from polymorphonuclear cells and monocytes: implications for acute coronary syndromes. Singh U; Devaraj S; Jialal I Clin Chem; 2009 Feb; 55(2):361-4. PubMed ID: 19074520 [TBL] [Abstract][Full Text] [Related]
11. The Dual Role of Myeloperoxidase in Immune Response. Arnhold J Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33137905 [TBL] [Abstract][Full Text] [Related]
12. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture. Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085 [TBL] [Abstract][Full Text] [Related]
14. Trans-vessel gradient of myeloperoxidase in coronary artery disease. Alipour A; Ribalta J; Njo TL; Janssen HW; Birnie E; van Miltenburg AJ; Elte JW; Castro Cabezas M Eur J Clin Invest; 2013 Sep; 43(9):920-5. PubMed ID: 23869443 [TBL] [Abstract][Full Text] [Related]
15. Intracellular localization of myeloperoxidase in murine peritoneal B-lymphocytes and macrophages. de Araujo TH; Okada SS; Ghosn EE; Taniwaki NN; Rodrigues MR; de Almeida SR; Mortara RA; Russo M; Campa A; Albuquerque RC Cell Immunol; 2013 Jan; 281(1):27-30. PubMed ID: 23434459 [TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease. van der Veen BS; de Winther MP; Heeringa P Antioxid Redox Signal; 2009 Nov; 11(11):2899-937. PubMed ID: 19622015 [TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease. Ndrepepa G Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769 [TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase and coronary arterial disease: from research to clinical practice. Roman RM; Wendland AE; Polanczyk CA Arq Bras Cardiol; 2008 Jul; 91(1):e11-9. PubMed ID: 18660935 [TBL] [Abstract][Full Text] [Related]
19. Serum myeloperoxidase levels and platelet activation parameters as diagnostic and prognostic markers in the course of coronary disease. Pawlus J; Hołub M; Kozuch M; Dabrowska M; Dobrzycki S Int J Lab Hematol; 2010 Jun; 32(3):320-8. PubMed ID: 20201999 [TBL] [Abstract][Full Text] [Related]
20. A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019). Soubhye J; Van Antwerpen P; Dufrasne F Expert Opin Ther Pat; 2020 Aug; 30(8):595-608. PubMed ID: 32510253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]